✨ Education and Health Notices
2 FEBRUARY 2006 NEW ZEALAND GAZETTE, No. 10 187
This notice shall take effect the day after the date of its
notification in the New Zealand Gazette.
KATHY PHILLIPS, Senior Manager, National Operations.
go640
Private Schools Conditional Integration Act 1975
Supplementary Integration Agreement
Pursuant to section 10 of the Private Schools Conditional Integration Act 1975, notice is given that a supplementary integration agreement has been signed between the Minister
of Education on behalf of Her Majesty the Queen, acting through the Senior Manager, National Operations, Ministry of Education, pursuant to delegated authority, and the proprietor of the following school:
St Bernadette’s School, Naenae.
The said supplementary integration agreement was executed on 27 January 2006.
A copy of the supplementary integration agreement is available for inspection without charge by any member of the public at the regional office of the Ministry of Education, Second Floor, 65 Waterloo Road, Lower Hutt.
Dated at Wellington this 27th day of January 2006.
KATHY PHILLIPS, Senior Manager, National Operations.
go587
Health
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Dimetapp Chest Congestion Paediatric Drops
Active Ingredient: Guaiphenesin 20mg/mL
Dosage Form: Syrup
New Zealand Sponsor: Wyeth Consumer Healthcare A Division of Wyeth (NZ) Limited
Manufacturers: Interphil Laboratories Inc, Pittland, Cabuyao, Laguna, Philippines
Sigma Pharmaceuticals Pty Limited, Clayton, Victoria, Australia
Product: Eloxatin
Active Ingredient: Oxaliplatin 5mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Aventis Pharma Limited
Manufacturer: Ben Venue Laboratories Inc, Bedford, Ohio, United States of America
Product: Septanest
Active Ingredients: Adrenaline acid tartrate 10µg/mL
Articaine hydrochloride 40mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Ivoclar Vivadent Limited
Manufacturer: Laboratoires Septodont, Saint-Maur-des-Fosses, Val-de-Marne, France
Dated this 27th day of January 2006.
BARRY BORMAN, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go574
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
Product: Natural Herbal and Mineral Toothpaste with Fluoride
Active Ingredient: Sodium monofluorophosphate 0.76%w/w
Dosage Form: Toothpaste
New Zealand Sponsor: Omegatrend New Zealand Limited
Manufacturer: Ross Cosmetics Pty Limited, Tullamarine, Victoria, Australia
Dated this 27th day of January 2006.
BARRY BORMAN, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go573
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2006, No 10
Gazette.govt.nz —
NZ Gazette 2006, No 10
✨ LLM interpretation of page content
🎓 Supplementary Integration Agreement for St Bernadette’s School
🎓 Education, Culture & Science27 January 2006
Private Schools Conditional Integration Act 1975, Supplementary Integration Agreement, St Bernadette’s School, Naenae
- KATHY PHILLIPS, Senior Manager, National Operations
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare27 January 2006
Medicines Act 1981, New Medicines, Dimetapp Chest Congestion Paediatric Drops, Eloxatin, Septanest
- BARRY BORMAN, Acting Deputy Director-General, Public Health
🏥 Consent to the Distribution of a New Related Product
🏥 Health & Social Welfare27 January 2006
Medicines Act 1981, New Related Product, Natural Herbal and Mineral Toothpaste with Fluoride
- BARRY BORMAN, Acting Deputy Director-General, Public Health